Recall date: June 2, 2026Official recall - FDA Drug
Med Pride Triple Antibiotic Ointment Recalled Over Inspection Deficiencies
An FDA recall record lists Med Pride Triple Antibiotic Ointment because of cGMP deviations and deficiencies observed during an FDA inspection. The product is described as 0.9g packets, with 144 packets per box and 130g total.
What matters now
- The affected product is Med Pride Triple Antibiotic Ointment.
- The recall reason is cGMP deviations and deficiencies observed during an FDA inspection.
- The product is described as 0.9g packets, with 144 packets per box and 130g total.
- Check the exact product against the current FDA record.
Product covered by the recall
The FDA record identifies Med Pride Triple Antibiotic Ointment containing bacitracin zinc equivalent to 400 units, neomycin sulfate 5 mg, and Polymixin B 5,000 units. It is described as 0.9g packets, with 144 packets per box and 130g total.
Why the ointment was recalled
The official recall reason is cGMP deviations and deficiencies observed during an FDA inspection.
How to identify the ointment
Look for the Med Pride product name and compare the listed active ingredients, 0.9g packet size, 144-packet box count, and 130g total weight with the current FDA record.
Action